These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 25980178)

  • 1. Sustained release matrix tablets prepared from cospray dried mixtures with starch hydrophobic esters.
    Sakhnini N; Al-Zoubi N; Al-Obaidi GH; Ardakani A
    Pharmazie; 2015 Mar; 70(3):177-82. PubMed ID: 25980178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Starch/Carbopol spray-dried mixtures as excipients for oral sustained drug delivery.
    Pringels E; Ameye D; Vervaet C; Foreman P; Remon JP
    J Control Release; 2005 Apr; 103(3):635-41. PubMed ID: 15820410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liquisolid compacts: the effect of cosolvent and HPMC on theophylline release.
    Nokhodchi A; Aliakbar R; Desai S; Javadzadeh Y
    Colloids Surf B Biointerfaces; 2010 Aug; 79(1):262-9. PubMed ID: 20451361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In-vitro and in-vivo evaluation of enteric-coated starch-based pellets prepared via extrusion/spheronisation.
    Dukić-Ott A; De Beer T; Remon JP; Baeyens W; Foreman P; Vervaet C
    Eur J Pharm Biopharm; 2008 Sep; 70(1):302-12. PubMed ID: 18579353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization and in vivo evaluation of ocular minitablets prepared with different bioadhesive Carbopol-starch components.
    Weyenberg W; Bozdag S; Foreman P; Remon JP; Ludwig A
    Eur J Pharm Biopharm; 2006 Feb; 62(2):202-9. PubMed ID: 16209917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent advances of starch-based excipients used in extended-release tablets: a review.
    Hong Y; Liu G; Gu Z
    Drug Deliv; 2016; 23(1):12-20. PubMed ID: 24833274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of drying procedure and of low degree of substitution on the structural and drug release properties of carboxymethyl starch.
    Lemieux M; Gosselin P; Mateescu MA
    AAPS PharmSciTech; 2010 Jun; 11(2):775-85. PubMed ID: 20443088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of powder blend and tablet structure on drug release mechanisms of hydrophobic starch acetate matrix tablets.
    van Veen B; Pajander J; Zuurman K; Lappalainen R; Poso A; Frijlink HW; Ketolainen J
    Eur J Pharm Biopharm; 2005 Oct; 61(3):149-57. PubMed ID: 16005196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Invivo absorption behaviour of theophylline from starch-methyl methacrylate matrix tablets in beagle dogs.
    Fernández-Campos F; Ferrero C; Colom H; Jiménez-Castellanos MR
    Int J Pharm; 2015 Jan; 478(2):684-92. PubMed ID: 25476254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Graft copolymers of ethyl methacrylate on waxy maize starch derivatives as novel excipients for matrix tablets: drug release and fronts movement kinetics.
    Marinich JA; Ferrero C; Jiménez-Castellanos MR
    Eur J Pharm Biopharm; 2012 Apr; 80(3):674-81. PubMed ID: 22210473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formulation study and drug release mechanism of a new theophylline sustained-release preparation.
    Hayashi T; Kanbe H; Okada M; Suzuki M; Ikeda Y; Onuki Y; Kaneko T; Sonobe T
    Int J Pharm; 2005 Nov; 304(1-2):91-101. PubMed ID: 16154302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of chitosan acetate as a binder for sustained release tablets.
    Nunthanid J; Laungtana-Anan M; Sriamornsak P; Limmatvapirat S; Puttipipatkhachorn S; Lim LY; Khor E
    J Control Release; 2004 Sep; 99(1):15-26. PubMed ID: 15342177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Robustness of Controlled Release Tablets Based on a Cross-linked Pregelatinized Potato Starch Matrix.
    Elgaied-Lamouchi D; Descamps N; Lefèvre P; Mackin-Mohamour AR; Neut C; Siepmann F; Siepmann J; Muschert S
    AAPS PharmSciTech; 2020 May; 21(5):148. PubMed ID: 32436061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of formulation parameters and drug-polymer interactions on drug release from starch acetate matrix tablets.
    Pajander J; Korhonen O; Laamanen M; Ryynänen EL; Grimsey I; van Veen B; Ketolainen J
    J Pharm Sci; 2009 Oct; 98(10):3676-90. PubMed ID: 19177516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro evaluation of gentamicin- and vancomycin-containing minitablets as a replacement for fortified eye drops.
    Bozdag S; Weyenberg W; Adriaens E; Dhondt MM; Vergote V; Vervaet C; De Prijck K; Nelis HJ; De Spiegeleer B; Ludwig A; Remon JP
    Drug Dev Ind Pharm; 2010 Nov; 36(11):1259-70. PubMed ID: 20545514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Compaction properties, drug release kinetics and fronts movement studies from matrices combining mixtures of swellable and inert polymers. II. Effect of HPMC with different degrees of methoxy/hydroxypropyl substitution.
    Escudero JJ; Ferrero C; Jiménez-Castellanos MR
    Int J Pharm; 2010 Mar; 387(1-2):56-64. PubMed ID: 19969052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro and in vivo sustained-release characteristics of theophylline matrix tablets and novel cluster tablets.
    Hayashi T; Kanbe H; Okada M; Kawase I; Ikeda Y; Onuki Y; Kaneko T; Sonobe T
    Int J Pharm; 2007 Aug; 341(1-2):105-13. PubMed ID: 17512147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxidized konjac glucomannan-cassava starch and sucrose esters as novel excipients for sustained-release matrix tablets.
    Liu C; Li J; Li K; Xie C; Liu J
    Int J Biol Macromol; 2020 Aug; 156():1045-1052. PubMed ID: 31756473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spray-dried O-carboxymethyl chitosan as potential hydrophilic matrix tablet for sustained release of drug.
    Bresolin JR; Largura MC; Dalri CC; Hoffer G; Rodrigues CA; Lucinda-Silva RM
    Drug Dev Ind Pharm; 2014 Apr; 40(4):503-10. PubMed ID: 23594298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of formulation and process variables on the release of a weakly basic drug from single unit extended release formulations.
    Kranz H; Wagner T
    Eur J Pharm Biopharm; 2006 Jan; 62(1):70-6. PubMed ID: 16154330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.